Cardiovascular Disease: Heart Failure/NIC

sec_arr References
SECTIONS

References

  1. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128:e240–e327. http://circ.ahajournals.org/content/128/16/e240.long. Accessed August 28, 2018.
  2. Varvarigou V, Farioli A, Korre M, et al. Law enforcement duties and sudden cardiac death among police officers in United States: case distribution study. BMJ. 2014;349:1-9. Available at: http://www.bmj.com/content/349/bmj.g6534. Accessed August 28, 2018.
  3. The Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 9th ed. Boston, Mass: Little & Brown; 1994.
  4. Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2009;53:1343-82.
  5. Braunwald E. Cardiomyopathies: an overview. Circulation Res. 2017;121: 711-21. Available at: http://circres.ahajournals.org/content/121/7/711.full. Accessed August 28, 2018.
  6. Hingorani P, Karnad DR, Rohekar P, et al. Arrhythmias seen in baseline 24-Hour Holter ECG recordings in healthy normal volunteers during phase 1 clinical trials. J Clin Pharmacol. 2016;56:885-93.
  7. Massing MW, Simpson RJ Jr, Rautaharju PM, et al. Usefulness of ventricular premature complexes to predict coronary heart disease events and mortality (from the Atherosclerosis Risk in Communities cohort). Am J Cardiol. 2006;98:1609-12.
  8. Ataklte F, Erqou S, Laukkanen J, et al. Meta-analysis of ventricular premature complexes and their relation to cardiac mortality in general populations. Am J Cardiol. 2013;112:1263-70.
  9. Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2017; Available at: http://circ.ahajournals.org/content/early/2017/10/30/CIR.0000000000000549. Accessed August 11, 2018.
  10. Thompson PD, Myerburg RJ, Levine BD, et al.; on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and the American College of Cardiology. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 8: coronary artery disease: a scientific statement from the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015;66:2406-11.
  11. Yancy CW, Jessup M, Bozkurt B, et al. ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2016;134:e282-93. http://www.hfsa.org/wp-content/uploads/2016/05/HF-Focused-Update-on-New-Pharmacological-Therapy_Final.pdf. Accessed August 28, 2018.
  12. Maron BJ, Udelson JE, Bonow RO, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis. Circulation. 2015;132:e273-e280. Available at: http://circ.ahajournals.org/content/132/22/e273.full. Accessed August 28, 2018.
  13. Madsen BK, Hansen JF, Stokholm KH, et al. Chronic congestive heart failure: description and survival of 190 consecutive patients with a diagnosis of chronic congestive heart failure based on clinical signs and symptoms. Eur Heart J. 1994;15:303-10.
  14. Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017.
  15. Ammar KA, Jacobsen SJ, Mahoney DW, et al. Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community. Circulation. 2007;115:1563-70.
  16. University of Washington. The Seattle Heart Failure Model. 2012. Available at: http://depts.washington.edu/shfm/. Accessed August 28, 2018.
  17. Marian AJ, Braunwald E. Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ Res. 2017;121:749-70.
  18. Blumenthal RS, Epstein AD, Kerber RE. Expert Panel Recommendations. Cardiovascular disease and commercial motor vehicle driver safety. Presented to Federal Motor Carrier Safety Administration 2007. Available at: https://www.fmcsa.dot.gov/sites/fmcsa.dot.gov/files/docs/Cardiovascular_Disease.pdf. Accessed August 27, 2018.
  19. Cooper LT Jr. Myocarditis. N Engl J Med. 2009;360:1526-38.
  20. Maron BM Maron BJ, Doerer JJ, et al. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation. 2009;119:1085-92.